Skip to content
This represents a 17.08 percent increase compared to the previous year, driven by stronger-than-expected tenant sales and a strategic expansion of its property portfolio.
This downturn follows a $44 million gain in January, which had lifted his stake to R10.26 billion ($550.1 million).
With this new mine, Seriti cements its lead as the largest black-controlled coal producer while securing a stable, long-term coal supply for power stations.
The deal will see Glencore’s joint venture with Merafe Resources oversee Sibanye’s chrome recovery plants in South Africa.
The move, disclosed in a regulatory filing on Friday, Feb. 14, 2025, reflects the continued focus of Heriot REIT.
In just six days, the market value of his stake has climbed by $4.06 million, bringing his total holdings to $124.26 million.
Discovery CEO and Co-founder Adrian Gore’s 2024 compensation package comprises a secure base pay of $448,843 and a performance-based short-term incentive of $565,687.
South African pharmaceutical tycoon Stephen Saad faces setback as Aspen Pharmacare shares decline.
This surge is driven by the sustained rise in the shares of the leading publisher of books, newspapers, and magazines on the Johannesburg Stock Exchange (JSE).
Although the recent surge boosted investor confidence, Transaction Capital shares remain down 57.28 percent year-to-date.
Attridge, who serves as the group’s chief advisor, holds a 4.3-percent stake in the Durban-based pharmaceutical giant, amounting to 19,033,829 shares.
This gain brings his total holdings to nearly $130 million, reinforcing his position as a leading figure in South Africa's media industry.
Real estate mogul Stephen Brookes, the founder and the largest shareholder of Balwin Properties, owns 36.08 percent of the Johannesburg-based property developer.
Ravazzotti’s stake in Italtile nears $330 million thanks to a $21.9-million gain in 14 days.
Saad's wealth drops by nearly $160 million after Aspen Pharmacare's shares tumble 20.17 percent over the past 25 days on the JSE.
Christopher Seabrooke’s stake in Sabvest Capital dips below $70 million as shares slide.